AI Clinical Trial Protocol Generator for Automated Design and Validation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current clinical trial protocol design processes are manual and labor-intensive, leading to sub-optimal implementations, data quality issues, delays, and resource inefficiencies due to the need for manual data consolidation and communication between multiple sources, which can result in inconsistencies and errors.

Innovation Solution

An AI and Machine Learning-based system that acquires raw data from disparate sources, processes it to deduce meaningful information, and uses a Trial Planning and Design module to generate a clinical trial protocol design document, incorporating pre-Drafted and regulatory protocols, with predictive validation and approval mechanisms, while also selecting investigators and patients based on correlated features and historical data.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If manual extraction of information from multiple sources is used to generate protocol designs, then flexibility and adaptability are maintained, but time consumption increases and data consistency deteriorates

Engineering Contradiction:
Improveprotocol design flexibilityVSAvoidtrial planning time
Core Design Contradiction:
Adaptability or versatilityVSLoss of time

Solution Approach 1:

The system segments the protocol design process into distinct modules: data acquisition from multiple sources, data processing and consolidation, protocol generation, and validation. This modular approach enables automated parallel processing of different data sources while maintaining the flexibility to customize each module, thereby reducing overall time consumption without sacrificing adaptability.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

An intermediary AI-based data consolidation engine is introduced between multiple data sources and the protocol generation process. This intermediary automatically standardizes and integrates data from diverse sources (electronic health records, research databases, regulatory documents), eliminating manual consolidation efforts while preserving the ability to adapt to different data formats and sources.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Loss of information

If manual data consolidation from various input sources is performed, then data from archived sources can be incorporated, but data inconsistencies and errors increase

Engineering Contradiction:
Improvecompleteness of dataVSAvoiddata consistency
Core Design Contradiction:
Loss of informationVSReliability

Solution Approach 1:

The system implements feedback mechanisms where the AI model continuously validates consolidated data against predefined consistency rules and quality metrics. Data from archived sources is cross-checked with current data sources, and discrepancies are automatically flagged and resolved through iterative refinement, ensuring high data consistency while maintaining completeness.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system dynamically adjusts data processing parameters based on the source and type of data being consolidated. Different transformation rules, validation thresholds, and integration strategies are applied to different data sources (e.g., structured EHR data vs. unstructured research notes), enabling reliable consolidation of diverse data while maintaining consistency standards.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If cross communication between Subject Matter Experts is required, then domain expertise is incorporated, but communication challenges and data inconsistencies arise

Engineering Contradiction:
Improvedomain expertise qualityVSAvoidcommunication infrastructure
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system enables Subject Matter Experts to contribute domain knowledge through self-service mechanisms such as annotated data validation, protocol template customization, and automated query resolution. Experts review and validate AI-generated protocol sections independently, providing domain expertise without requiring extensive inter-expert communication, thereby reducing communication complexity while maintaining expertise quality.

Inventive Principle:
Principle #25Self-service

4Manufacturing precision

If manual protocol design tasks are performed, then detailed control over protocol elements is maintained, but productivity and efficiency decrease

Engineering Contradiction:
Improveprotocol design accuracyVSAvoidprotocol generation speed
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The system performs preliminary actions by pre-processing data from multiple sources, pre-validating data quality, and pre-generating protocol sections using AI models before final assembly. This preliminary work ensures high accuracy in data consolidation and protocol elements, while the automated nature of these preliminary steps significantly increases overall productivity compared to manual processes.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS11521713B2System and method for generating clinical trial protocol design document with selection of patient and investigator
Publication Date: 2022.12.06 HCL TECH LTD
  • US11521713B2 patent drawing
  • US11521713B2 patent drawing
  • US11521713B2 patent drawing

AI summary

Disclosed is a system for generating Clinical trial protocol design document with selection of a Patient and an Investigator for a clinical trial process. The system inputs meaningful information derived from the raw data, a pre-Drafted protocol, a regulatory authorities' protocol curated by regulatory authorities, and a pre-stored dataset, present in a repository. A Clinical trial protocol design document is drafted by generating a case frame upon extracting data in form of a key value into a standard document. Each key value is validated and a prediction score is computed based on overlapping of the interim Clinical trial protocol design template with the pre-Drafted protocol and the regulatory authorities' protocol to determine whether the interim Clinical trial protocol design document is approved or rejected. A Clinical trial protocol design document is generated when the interim Clinical trial protocol design document is approved.